Supernus Pharmaceuticals
SUPN
$46.24
Share price
-2.18%
Change (1 day)
4.80%
Change (1 year)
Categories
Revenue for Supernus Pharmaceuticals (SUPN)
Revenue in 2024 (TTM): C$0.91 Billion
According to Supernus Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is C$0.94 Billion. an increase over the revenue in the year 2023 that were of C$0.80 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Supernus Pharmaceuticals from 2011 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | C$0.94 B | 17.86% |
| 2023 | C$0.80 B | -11% |
| 2022 | C$0.90 B | 22.54% |
| 2021 | C$0.73 B | 11.36% |
| 2020 | C$0.66 B | 29.36% |
| 2019 | C$0.51 B | -7.91% |
| 2018 | C$0.55 B | 46.58% |
| 2017 | C$0.37 B | 31.51% |
| 2016 | C$0.28 B | 42.24% |
| 2015 | C$0.20 B | 89.76% |
| 2014 | C$0.10 B | 736.62% |
| 2013 | C$12.79 M | 770% |
| 2012 | C$1.47 M | -115.92% |
| 2011 | -C$9.25 Million |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$0.11 B | -87.66% | 🇺🇸 USA |
 | C$4.11 B | 334.77% | 🇺🇸 USA |
 | C$64.42 B | 6,705.91% | 🇺🇸 USA |
 | C$69.08 B | 7,198.09% | 🇺🇸 USA |
 | C$60.00 B | 6,238.61% | 🇺🇸 USA |
 | C$127.04 B | 13,320.78% | 🇺🇸 USA |